Wataru Omori, Narumi Kodaka, Kenichi Oga, Yoshikazu Masuda, Go Okada
{"title":"Electroconvulsive therapy in an older patient with recurrent major depressive disorder and a permanent pacemaker: A case report.","authors":"Wataru Omori, Narumi Kodaka, Kenichi Oga, Yoshikazu Masuda, Go Okada","doi":"10.1002/pcn5.70348","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Electroconvulsive therapy (ECT) is highly effective for severe or treatment-resistant major depressive disorder, including in older adults. In patients with permanent pacemakers, however, ECT may be avoided because of concern about device malfunction or arrhythmia.</p><p><strong>Case presentation: </strong>We report a man in his 80s with recurrent major depressive disorder and a dual-chamber pacemaker for complete atrioventricular block. During the approximately 2 years before admission, the depressive episode achieved only partial remission despite mirtazapine 30 mg/day and trials of duloxetine 60 mg/day and venlafaxine 150 mg/day, then worsened acutely. Vortioxetine was introduced after admission, but severe symptoms persisted. Pre-ECT interrogation confirmed pacemaker dependence with only minimal intrinsic ventricular activity. After multidisciplinary preparation, approximately twice-weekly ECT was initiated using a Thymatron System IV device with initial bitemporal placement; stimulus dosing initially followed the half-age method, beginning at 40% (202 mC) with a brief-pulse stimulus. As seizure induction became difficult, augmentation included hyperventilation, theophylline premedication, switching to right unilateral placement, and ketamine anesthesia. Continuous monitoring and peri-ECT device checks showed stable function; no magnet application or reprogramming was required. The patient received 20 treatments. The 21-item GRID Hamilton Depression Rating Scale (GRID-HAM-D) score improved from 32 before ECT to 2 after the acute course. Mood, anxiety, appetite, and physical strength improved early, followed by more gradual improvement in psychomotor retardation. No clinically significant arrhythmias, pacemaker malfunction, oversensing, pacing inhibition, or serious hemodynamic complications occurred.</p><p><strong>Conclusion: </strong>This case supports the feasibility of carefully planned ECT in selected older patients with permanent pacemakers, provided that multidisciplinary planning and practical device precautions are in place.</p>","PeriodicalId":74405,"journal":{"name":"PCN reports : psychiatry and clinical neurosciences","volume":"5 ","pages":"e70348"},"PeriodicalIF":1.3000,"publicationDate":"2026-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13183783/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PCN reports : psychiatry and clinical neurosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pcn5.70348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Electroconvulsive therapy (ECT) is highly effective for severe or treatment-resistant major depressive disorder, including in older adults. In patients with permanent pacemakers, however, ECT may be avoided because of concern about device malfunction or arrhythmia.
Case presentation: We report a man in his 80s with recurrent major depressive disorder and a dual-chamber pacemaker for complete atrioventricular block. During the approximately 2 years before admission, the depressive episode achieved only partial remission despite mirtazapine 30 mg/day and trials of duloxetine 60 mg/day and venlafaxine 150 mg/day, then worsened acutely. Vortioxetine was introduced after admission, but severe symptoms persisted. Pre-ECT interrogation confirmed pacemaker dependence with only minimal intrinsic ventricular activity. After multidisciplinary preparation, approximately twice-weekly ECT was initiated using a Thymatron System IV device with initial bitemporal placement; stimulus dosing initially followed the half-age method, beginning at 40% (202 mC) with a brief-pulse stimulus. As seizure induction became difficult, augmentation included hyperventilation, theophylline premedication, switching to right unilateral placement, and ketamine anesthesia. Continuous monitoring and peri-ECT device checks showed stable function; no magnet application or reprogramming was required. The patient received 20 treatments. The 21-item GRID Hamilton Depression Rating Scale (GRID-HAM-D) score improved from 32 before ECT to 2 after the acute course. Mood, anxiety, appetite, and physical strength improved early, followed by more gradual improvement in psychomotor retardation. No clinically significant arrhythmias, pacemaker malfunction, oversensing, pacing inhibition, or serious hemodynamic complications occurred.
Conclusion: This case supports the feasibility of carefully planned ECT in selected older patients with permanent pacemakers, provided that multidisciplinary planning and practical device precautions are in place.
背景:电痉挛疗法(ECT)对重度或难治性重度抑郁症非常有效,包括老年人。然而,对于装有永久性起搏器的患者,由于担心装置故障或心律失常,可以避免电痉挛治疗。病例介绍:我们报告一位80多岁的男性复发性重度抑郁症和双室起搏器完全性房室传导阻滞。在入院前大约2年的时间里,尽管米氮平30毫克/天,度洛西汀60毫克/天,文拉法辛150毫克/天的试验,抑郁发作只获得部分缓解,然后急剧恶化。入院后引入沃替西汀,但严重症状持续存在。电休克前的问询证实心脏起搏器依赖,只有极小的内在心室活动。在多学科准备后,使用胸腺管系统IV装置开始大约每周两次ECT,初始双颞部放置;刺激剂量最初采用半龄法,从40% (202mc)开始进行短脉冲刺激。当癫痫诱导变得困难时,增强包括过度通气、茶碱预用药、切换到右侧单侧放置和氯胺酮麻醉。连续监测和ect设备检查功能稳定;不需要磁铁应用或重新编程。患者接受了20次治疗。21项GRID汉密尔顿抑郁评定量表(GRID- ham - d)评分由ECT前的32分提高到急性疗程后的2分。情绪、焦虑、食欲和体力在早期得到改善,随后精神运动迟缓得到更渐进的改善。无明显临床意义的心律失常、起搏器功能障碍、过度敏感、起搏抑制或严重的血流动力学并发症发生。结论:本病例支持在多学科规划和实用的设备预防措施到位的情况下,对选择的老年永久性起搏器患者进行精心计划的ECT的可行性。